Warby Parker
WRBY
23.12
-1.01
-4.19%
Warby Parker
US · WRBY
#2446 by market cap
Listed 2021
23.12
-1.01
-4.19%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
A Quick Look at Today's Ratings for Warby Parker(WRBY.US), With a Forecast Between $31 to $34Market Newswire · 2026/5/8
-
UBS Maintains Warby Parker(WRBY.US) With Hold Rating, Maintains Target Price $32Market Newswire · 2026/11/9
-
Rating change
Goldman Sachs Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $31Market Newswire · 2026/5/8
-
Earnings Flash (WRBY) Warby Parker Posts Q3 EPS $0.04, Vs. FactSet Est of $0.03MT Newswires · 2026/11/5
-
Rating change
Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $33Market Newswire · 2026/7/31
-
Rating change
Goldman Sachs Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $32Market Newswire · 2026/9/16
-
Rating change
A Quick Look at Today's Ratings for Warby Parker(WRBY.US), With a Forecast Between $27 to $33Market Newswire · 2026/8/8
-
Rating change
BTIG Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $34Market Newswire · 2026/8/14
-
Rating change
Stifel Maintains Warby Parker(WRBY.US) With Hold RatingMarket Newswire · 2026/5/20
-
Rating change
Analysts Offer Insights on Healthcare Companies: Warby Parker (WRBY), Omada Health, Inc. (OMDA) and CAMP4 Therapeutics Corporation (CAMP)TipRanks · 2026/5/8
-
Rating change
William Blair Maintains Warby Parker(WRBY.US) With Buy RatingMarket Newswire · 2026/8/4
-
Rating change
TD Cowen Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $32Market Newswire · 2026/8/13
-
Rating change
Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $32Market Newswire · 2026/4/30
-
BofA Securities Initiates Warby Parker(WRBY.US) With Buy Rating, Announces Target Price $33Market Newswire · 2026/11/3
-
Rating change
Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA), Warby Parker (WRBY) and Aprea Therapeutics (APRE)TipRanks · 2026/8/13
-
Rating change
BTIG Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $32Market Newswire · 2026/5/1
-
Rating change
TD Cowen Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $32Market Newswire · 2026/5/9
-
Piper Sandler Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $32Market Newswire · 2026/11/3
-
A Quick Look at Today's Ratings for Warby Parker(WRBY.US), With a Forecast Between $27 to $40Market Newswire · 2026/11/7
-
Rating change
A Quick Look at Today's Ratings for Warby Parker(WRBY.US), With a Forecast Between $28 to $33Market Newswire · 2026/8/7
-
Piper Sandler Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $32Market Newswire · 2026/9/2
-
Rating change
TD Cowen Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $30Market Newswire · 2026/2/27
-
Rating change
Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $32Market Newswire · 2026/2/27
-
Rating change
Citi Maintains Warby Parker(WRBY.US) With Hold Rating, Maintains Target Price $24Market Newswire · 2026/3/18
-
Rating change
BofA Securities Initiates Warby Parker(WRBY.US) With Buy Rating, Announces Target Price $33Market Newswire · 2026/6/29
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Warby Parker discussion 0 comments